Symphogen
Janus Schou Jakobsen has a diverse background in scientific research, with experience ranging from stem cell and cancer research to molecular biology and developmental biology. Currently holding multiple titles at Symphogen and Rotapure Lab Instruments, Janus has also worked as an Assistant Professor at BRIC. With a Masters in Human Biology and a PhD in Molecular Biology, Janus is skilled in deciphering stem cell regulation and its relation to epithelial cancers.
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.